KDM4B and MLL2 synergistically regulate cancer cell proliferation through their target genes, including myeloblastosis (MYB), myelocytomatosis (MYC), and cyclin D1 (CCND1) [25,26]. This evidence concerns the gene CCND1 and cancer.